|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|
| Operating activities | |
| Net loss | |
| Adjustments to reconcile net loss to net cash used in operating activities: | |
| Depreciation and amortization expense | |
| Stock-based compensation expense | |
| Non-cash interest expense | |
| Loss on lease termination | |
| Impairment of long-lived assets | |
| Issuance of preferred stock for services rendered | |
| Loss on debt extinguishment | |
| (Gain) loss on change in fair value of warrant liabilities | |
| Unrealized foreign exchange loss | |
| Benefit from income tax | |
| Other | |
| Changes in operating assets and liabilities: | |
| Accounts receivable | |
| Accounts receivable, unbilled | |
| Prepaid expenses | |
| Inventories | |
| Other current assets | |
| Other long-term assets | |
| Accounts payable | |
| Accrued and other liabilities | |
| Deferred revenue | |
| Deferred rent | |
| Other long-term liabilities | |
| Net cash used in operating activities | |
| Investing activities | |
| Purchases of property and equipment | |
| Proceeds from sale of property and equipment | |
| Business acquisition, net of cash acquired | |
| Net cash used in investing activities | |
| Financing activities | |
| Proceeds from initial public offering, net of commission and issuance cost | |
| Proceeds from exercise of Series C warrants | |
| Proceeds from repayment of non-recourse loan to employee | |
| Proceeds from Series preferred stock offering, net of issuance cost | |
| Proceeds from long-term debt, net of offering cost | |
| Proceeds from exercise of common stock options, net of repurchases | |
| Proceeds from ESPP | |
| Tax withholding for net share settlements of RSUs | |
| Payments on debt | |
| Payments on build-to-suit property obligations | |
| Net cash provided by financing activities | |
| Effect of exchange rate changes on cash | |
| Change in cash and cash equivalents | |
| Cash, cash equivalents, and restricted cash at beginning of the period | |
| Cash, cash equivalents, and restricted cash at end of the period | |
| Supplemental disclosure of cash flow information: | |
| Cash paid during the period for interest | |
| Supplemental disclosure of non-cash investing and financing activities: | |
| Conversion of preferred shares to common stock | |
| Exercise of warrant liability into preferred stock | |
| Share settlement of non-recourse loan to employee | |
| Issuance of common stock upon cashless exercise of warrants | |
| Issuance of common stock in business combination | |
| Acquisitions of property and equipment under accounts payable and accrued and other liabilities | |
| Deferred offering costs related to initial public offering under accounts payable and accrued and other liabilities | |
| Deferred offering costs related to Series D preferred stock under accounts payable and accrued and other liabilities | |
| Warrants issued in connection with debt | |
| Cash and cash equivalents | |
| Restricted cash, current | |
| Restricted cash, non-current |
Loading...
